Liping Huang Selected Research

Antiviral Agents (Antivirals)

9/2022	Specific inhibition of the interaction between pseudorabies virus DNA polymerase subunits UL30 and UL42 by a synthetic peptide.
11/2018	Liver Fibrosis with Two-dimensional US Shear-Wave Elastography in Participants with Chronic Hepatitis B: A Prospective Multicenter Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liping Huang Research Topics

Disease

27	Neoplasms (Cancer) 05/2024 - 03/2006
23	Reperfusion Injury 01/2022 - 09/2003
19	Inflammation (Inflammations) 01/2023 - 02/2004
18	Infections 01/2024 - 07/2003
17	Stroke (Strokes) 03/2024 - 06/2017
11	Hypertension (High Blood Pressure) 03/2024 - 12/2017
10	Ischemia 01/2022 - 09/2003
7	Insulin Resistance 01/2023 - 09/2012
7	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 09/2003
7	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 09/2008
6	Melanoma (Melanoma, Malignant) 02/2023 - 01/2018
6	Neoplasm Metastasis (Metastasis) 02/2023 - 07/2017
6	COVID-19 03/2022 - 05/2020
6	Fibrosis (Cirrhosis) 01/2022 - 04/2017
5	Ovarian Neoplasms (Ovarian Cancer) 05/2024 - 07/2017
5	Body Weight (Weight, Body) 11/2023 - 12/2007
4	Pneumococcal Infections 03/2024 - 01/2022
4	Pneumonia (Pneumonitis) 03/2023 - 07/2015
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 03/2006
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023 - 01/2011
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2015
4	Pre-Eclampsia (Preeclampsia) 01/2021 - 01/2018
3	Syphilis 04/2024 - 05/2020
3	Heart Diseases (Heart Disease) 04/2024 - 04/2014
3	Heart Failure 03/2024 - 02/2004
3	Ischemic Stroke 12/2023 - 01/2022
3	Weight Loss (Weight Reduction) 03/2023 - 04/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2023 - 10/2018
3	Brain Ischemia (Cerebral Ischemia) 01/2023 - 04/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 01/2020
3	Pain (Aches) 10/2022 - 09/2017
3	Hypoxia (Hypoxemia) 01/2022 - 06/2010
3	Dermatitis 12/2021 - 12/2007
3	Breast Neoplasms (Breast Cancer) 06/2021 - 07/2015
3	Meningococcal Infections 01/2021 - 01/2020
3	Amyloid Plaque 01/2020 - 09/2008
3	Parkinson Disease (Parkinson's Disease) 10/2017 - 09/2014
2	Embolic Stroke 12/2023 - 08/2023
2	Chronic Renal Insufficiency 01/2023 - 01/2020
2	Proteinuria 11/2022 - 01/2020
2	Renal Insufficiency (Renal Failure) 01/2022 - 01/2021
2	Hypersensitivity (Allergy) 12/2021 - 01/2021
2	Infarction (Infarctions) 01/2021 - 04/2013
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 10/2020 - 08/2020

Drug/Important Bio-Agent (IBA)

17	SaltsIBA 03/2024 - 06/2017
16	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2016
13	VaccinesIBA 05/2023 - 10/2013
13	ZincIBA 01/2023 - 02/2004
12	SodiumIBA 02/2024 - 06/2017
12	Biomarkers (Surrogate Marker)IBA 12/2023 - 08/2014
11	PotassiumIBA 03/2024 - 12/2017
10	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 04/2005
7	AntibodiesIBA 04/2024 - 06/2014
7	LipidsIBA 11/2023 - 01/2017
6	EnzymesIBA 05/2024 - 09/2012
6	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2017 - 06/2006
5	AntioxidantsIBA 05/2024 - 03/2018
5	Small Interfering RNA (siRNA)IBA 07/2021 - 12/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 04/2014
4	AntigensIBA 04/2024 - 07/2003
4	CreatinineIBA 12/2023 - 07/2013
4	LigandsIBA 01/2023 - 01/2015
4	Peptides (Polypeptides)IBA 09/2022 - 09/2008
4	Immunoglobulin M (IgM)IBA 01/2022 - 02/2012
4	Messenger RNA (mRNA)IBA 10/2020 - 09/2012
4	zinc-binding protein (zinc binding protein)IBA 01/2018 - 09/2011
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 09/2012
3	Conjugate VaccinesIBA 01/2024 - 01/2022
3	CytokinesIBA 12/2023 - 02/2004
3	Folic Acid (Vitamin M)FDA LinkGeneric 09/2022 - 04/2017
3	Superoxide DismutaseIBA 03/2022 - 08/2020
3	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2020
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2022 - 09/2003
3	Transaminases (Aminotransferases)IBA 09/2021 - 02/2004
3	Nucleic AcidsIBA 01/2021 - 08/2013
3	Contrast MediaIBA 01/2020 - 11/2015
3	CelluloseIBA 01/2020 - 11/2015
3	SphingosineIBA 04/2017 - 06/2006
3	Amyloid beta-PeptidesIBA 12/2016 - 09/2008
3	Sphingosine-1-Phosphate ReceptorsIBA 04/2016 - 06/2010
2	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2020
2	Antiviral Agents (Antivirals)IBA 09/2022 - 11/2018
2	CollagenIBA 03/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2019
2	Polysaccharides (Glycans)IBA 01/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2018
2	sphingosine kinaseIBA 01/2022 - 04/2017
2	AcidsIBA 01/2022 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2020
2	Trichloroethylene (Trichloroethene)IBA 12/2021 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 06/2021 - 12/2017
2	Beclin-1IBA 01/2021 - 10/2020

Therapy/Procedure

18	Therapeutics 11/2023 - 09/2012
3	Electroacupuncture 01/2024 - 04/2013
3	Drug Therapy (Chemotherapy) 01/2023 - 12/2017
3	Immunotherapy 01/2023 - 10/2019
3	Aftercare (After-Treatment) 01/2022 - 09/2017
2	Nutritional Support (Artificial Feeding) 01/2023 - 01/2022
2	Enteral Nutrition (Feeding, Tube) 01/2022 - 01/2020